Mrkt BUZZ Pila Pharma: Receives go-ahead for start of obesity trials

2026-08-18 15:55:00

Carlsquare Equity Research has published a comment on today’s news regarding EMA approval for the start of a new clinical trial for XEN-D0501.

Read the comment here.

About Carlsquare

Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more